- Home
- HNST vs MYGN Comparison
HNST vs MYGN Comparison
Compare HNST & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HNST | MYGN |
|---|---|---|
| Founded | 2012 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 375.4M | 444.2M |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | HNST | MYGN |
|---|---|---|
| Price | $3.67 | $4.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $3.05 | ★ $7.64 |
| AVG Volume (30 Days) | 1.4M | ★ 1.5M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $371,317,000.00 | ★ $771,400,000.00 |
| Revenue This Year | N/A | $6.86 |
| Revenue Next Year | $5.93 | $5.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 2.33 |
| 52 Week Low | $2.07 | $3.53 |
| 52 Week High | $5.28 | $8.59 |
Technical Indicators
Market Signals| Indicator | HNST | MYGN |
|---|---|---|
| Relative Strength Index (RSI) | 61.08 | 50.65 |
| Support Level | $3.15 | $4.31 |
| Resistance Level | $3.71 | $4.92 |
| Average True Range (ATR) | 0.16 | 0.30 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 92.23 | 48.26 |
Price Performance
Historical ComparisonAbout HNST The Honest Company Inc.
The Honest Co Inc is a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults. By combining thoughtful design with science-based innovation, the company delivers personal care products for everyone from babies to adults, spanning categories across wipes, personal care, diapers, and beauty. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.